Vor Bio reports Q1 EPS (45c), consensus (38c)
PremiumThe FlyVor Bio reports Q1 EPS (45c), consensus (38c)
3M ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3M ago
Vor Biopharma Welcomes Oncology Expert to Board of Directors
PremiumCompany Announcements
Vor Biopharma Welcomes Oncology Expert to Board of Directors
3M ago
Vor Bio reports Q4 EPS (39c), consensus (50c)
PremiumThe FlyVor Bio reports Q4 EPS (39c), consensus (50c)
4M ago
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results  and Provides Company Update
PremiumPress Releases
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
4M ago
VOR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VOR Upcoming Earnings Report: What to Expect?
4M ago
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress ReleasesVor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
6M ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6M ago
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
PremiumPress Releases
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100